Skip to main content
. 2017 Nov 17;8(65):109107–109119. doi: 10.18632/oncotarget.22619

Table 5. Stratified analyses between LEPR rs1137101 G>A polymorphism and ESCC risk by sex, age, BMI, smoking status and alcohol consumption.

Variable LEPR rs1137101 G>A (case/control)a Adjusted ORb (95% CI); P
GG GA AA GG GA AA GA/AA AA vs. (GA/GG)
Sex
Male 292/832 78/235 5/11 1.00 0.84(0.61-1.15);
P: 0.275
1.52(0.49-4.75);
P: 0.473
0.87(0.64-1.18);
P: 0.353
1.57(0.50-4.91);
P: 0.435
Female 98/314 30/87 1/10 1.00 1.11(0.68-1.81);
P: 0.686
0.27(0.03-2.24);
P: 0.226
1.02(0.63-1.65);
P: 0.943
0.27 (0.03-2.20);
P: 0.220
Age
<63 177/579 55/157 4/11 1.00 1.06 (0.72-1.57);
P: 0.772
1.77 (0.51-6.13);
P: 0.370
1.09(0.74-1.59);
P: 0.666
1.73(0.50-5.98);
P: 0.387
≥63 213/567 53/165 2/10 1.00 0.75(0.52-1.08);
P: 0.123
0.43(0.09-2.02);
P: 0.283
0.74(0.52-1.06);
P: 0.097
0.46(0.10-2.16);
P: 0.323
Smoking status
Never 186/848 56/221 3/17 1.00 1.15(0.82-1.61);
P: 0.432
0.72(0.20-2.56);
P: 0.613
1.12(0.80-1.57);
P: 0.504
0.70(0.20-2.49);
P: 0.585
Ever 204/298 52/101 3/4 1.00 0.66(0.44-1.00);
P: 0.049
1.51(0.30-7.58);
P: 0.616
0.68(0.46-1.02);
P: 0.063
1.65 (0.33-8.24);
P: 0.543
Alcohol consumption
Never 260/1,028 73/276 5/19 1.00 1.00(0.74-1.35);
P: 0.999
1.04(0.37-2.89);
P: 0.943
1.01(0.75-1.35);
P: 0.953
1.04(0.38-2.89);
P: 0.939
Ever 130/118 35/46 1/2 1.00 0.54(0.31-0.95);
P: 0.031
0.56(0.04-8.70);
P: 0.679
0.54(0.31-0.93);
P: 0.027
0.64(0.04-9.68);
P: 0.750
BMI (kg/m2)
<24 279/600 83/165 5/9 1.00 0.99(0.72-1.36);
P: 0.930
1.32(0.42-4.18);
P: 0.633
1.01(0.74-1.38);
P: 0.972
1.33(0.42-4.20);
P: 0.623
≥24 111/546 25/157 1/12 1.00 0.76(0.47-1.22);
P: 0.250
0.39(0.05-3.12);
P: 0.376
0.73(0.45-1.16);
P: 0.183
0.41(0.05-3.29);
P: 0.405

a For LEPR rs1137101 G>A, the genotyping was successful in 507 (99.41%) ESCC cases, and 1,496 (99.53%) controls.

b Adjusted for multiple comparisons [age, sex, BMI, smoking status and alcohol consumption (besides stratified factors accordingly)] in a logistic regression model.